Number of research projects Implementation of a Technology-driven AMSP program Steered by Clinicians to Improve Antimicrobial Prescribing: a multi-centric mixed-methods study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2028
Project Lead
Dr Savitha Nagaraj
Authors
Dr Savitha Nagaraj
Project Status
ongoing
Project Type
ICMR IIRPIG-2023-001295